Displaying drugs 876 - 900 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Sulfacytine | 294.33 C12H14N4O3S |  | Used orally in the treatment of acute urinary tract infections. | Sulfonamides |
| Dotatate | 1435.63 C65H90N14O19S2 |  | Not Annotated | Radioactive Diagnostic Agent |
| Solriamfetol | 194.234 C10H14N2O2 |  | Solriamfetol is indicated for treatment of daytime sleepiness associated with obstructive sleep apnea and narcolepsy, but is not a treatment for the underlying airway obstruction in apnea patients[FDA Label][A176534,A176744]. | Centrally Acting Sympathomimetics |
| Tegafur | 200.169 C8H9FN2O3 |  | An antineoplastic agent used in combination with other anticancer medications to treat advanced gastric and colorectal cancers. | Pyrimidine Analogues |
| Ritlecitinib | 285.351 C15H19N5O |  | A kinase inhibitor used to treat severe alopecia areata in adults and adolescents 12 years and older. | Janus Kinase Inhibitor |
| Bortezomib | 384.237 C19H25BN4O4 |  | A proteasome inhibitor used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies. | Boronic Acids / Proteasome Inhibitors / Pyrazines |
| Prucalopride | 367.87 C18H26ClN3O3 |  | A 5-HT4 receptor agonist indicated to treat adults with chronic idiopathic constipation. | Laxatives / Serotonin 5-HT4 Receptor Agonists / Serotonin-4 Receptor Agonist |
| Lisuride | 338.4466 C20H26N4O |  | For the management of Parkinson's Disease | Ergot Alkaloids and Derivatives / Prolactine Inhibitors |
| Repotrectinib | 355.373 C18H18FN5O2 |  | A tyrosine kinase inhibitor used to treat locally active or metastatic non-small cell lung cancer | BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Inhibitors / Cytochrome P-450 CYP3A5 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Kinase Inhibitor / MATE 2 Inhibitors / MATE inhibitors / OATP1B1/SLCO1B1 Inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates / ROS1 tyrosine kinase inhibitors / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors |
| Ferric pyrophosphate citrate | 1321.571 C18H24Fe4O42P6 |  | A soluble iron compound used to maintain hemoglobin levels in patients undergoing hemodialysis. | Parenteral Iron Replacement |
| Berotralstat | 562.573 C30H26F4N6O |  | An inhibitor of plasma kallikrein used for prophylaxis of angioedema attacks in patients with hereditary angioedema. | Plasma Kallikrein Inhibitor / Serine Protease Inhibitors |
| Lasofoxifene | 413.5512 C28H31NO2 |  | Investigated for use/treatment in postmenopausal osteoporosis to reduce the risk of both vertebral and novertebral fractures, as well as address other postmenopausal conditions, including reduction in risk of breast cancer... | Selective Estrogen Receptor Modulators |
| Remdesivir | 602.585 C27H35N6O8P |  | A nucleoside analog used to treat RNA virus infections including COVID-19. | Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors |
| Bromazepam | 316.153 C14H10BrN3O |  | A short-acting benzodiazepine with intermediate onset commonly used to treat panic disorders and severe anxiety. | Anti-Anxiety Agents |
| Valdecoxib | 314.359 C16H14N2O3S |  | A COX-2 inhibitor used to treat osteoarthritis and dysmenorrhoea. | COX-2 Inhibitors / Selective Cyclooxygenase 2 Inhibitors (NSAIDs) |
| Brilliant green cation | 385.574 C27H33N2 |  | An ingredient used in topical medications to prevent infections of the umbilical cord. | Anti-Infective Agents, Local / Coloring Agents |
| Phenylbutyric acid | 164.2011 C10H12O2 |  | An agent indicated for the adjunctive therapy for the management of chronic urea cycle disorders due to deficiencies in specific enzymes, including the neonatal-onset deficiency and late-onset disease with a history of hyperammonemic encephalopathy. | Various Alimentary Tract and Metabolism Products |
| Arzoxifene | 475.6 C28H29NO4S |  | Investigated for use/treatment in breast cancer, osteoporosis, and endometrial cancer. | Sulfur Compounds |
| Lomitapide | 693.7204 C39H37F6N3O2 |  | A microsomal triglyceride transfer protein inhibitor used to lower cholesterol associated with homozygous familial hypercholesterolemia (HoFH), reducing risk of cardiovascular events such as myocardial infarction and stroke. | Hypolipidemic Agents Indicated for Hyperlipidemia / Microsomal Triglyceride Transfer Protein Inhibitor |
| Risdiplam | 401.474 C22H23N7O |  | An oral mRNA splicing modifier used in the treatment of spinal muscular atrophy (SMA). | BCRP/ABCG2 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Substrates / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / Musculo-Skeletal System / Other Miscellaneous Therapeutic Agents / P-glycoprotein substrates / Peripheral Nervous System Agents / Survival Motor Neuron-2-directed RNA Interaction / Survival of Motor Neuron 2 Splicing Modifier |
| Colesevelam | Not Available |  | A bile acid sequestrant used to lower LDL-C in adults with hyperlipidemia and pediatric patients with heterozygous familial hypercholesterolemia, and to improve glycemic control in type 2 diabetes. | Allylamine / Anticholesteremic Agents / Bile Acid Sequestrants / Hypolipidemic Agents Indicated for Hyperlipidemia |
| Cabazitaxel | 835.9324 C45H57NO14 |  | An antineoplastic agent used in combination with corticosteroids to treat metastatic castration-resistant prostate cancer in patients previously treated with a docetaxel-containing treatment regimen. | Taxoids |
| Tipiracil | 242.662 C9H11ClN4O2 |  | A thymidine phosphorylase inhibitor used as an adjunct treatment of adult patients with certain types of gastric or colorectal malignancies. | Thymidine Phosphorylase Inhibitor |
| Clindamycin | 424.98 C18H33ClN2O5S |  | A lincosamide antibiotic used to treat serious infections caused by susceptible anaerobic, streptococcal, staphylococcal, and pneumococcal bacteria. | Antiinfectives for Treatment of Acne / Lincosamides |
| Erlotinib | 393.4357 C22H23N3O4 |  | An EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
Displaying drugs 876 - 900 of 2785 in total